AMGEN INC — Director's Dealing 2020

Jul 2, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2020-06-24

Reporting Person: Grygiel Nancy A. (SVP & CCO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3142	Direct
Common Stock	88.786	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Nqso (Right to Buy)	$162.60	2027-05-01	Common Stock (4139)		Direct
Nqso (Right to Buy)	$177.46	2028-04-27	Common Stock (3470)		Direct
Nqso (Right to Buy)	$177.31	2029-05-03	Common Stock (3948)		Direct
Nqso (Right to Buy)	$236.36	2030-05-05	Common Stock (3542)		Direct

Footnotes

F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 748 RSUs which fully vest on 8/1/2020; 159 RSUs which fully vest on 5/1/2021; 302 RSUs which vest in two installments of 149 on 4/27/2021 and 153 on 4/27/2022; 452 RSUs which vest in two installments of 149 on 5/3/2021 and 5/3/2022 and one installment of 154 on 5/3/2023; and 423 RSUs which vest in installments of 139 on 5/5/2022, 140 on 5/5/2023 and 144 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2: These shares include 142 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

F3: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.

F4: 2,731 of these non-qualified stock options have vested and are exercisable and 1,408 of these options will vest and become exercisable on 5/1/2021.

F5: 1,145 of these non-qualified stock options have vested and are exercisable and the remaining options will vest and become exercisable in installments of 1,145 on 4/27/2021 and 1,180 on 4/27/2022.

F6: These non-qualified stock options will vest and become exercisable in three installments of 1,302 on 5/3/2021, 1,303 on 5/3/2022 and 1,343 on 5/3/2023.

F7: These non-qualified stock options will vest and become exercisable in three installments of 1,168 on 5/5/2022, 1,169 on 5/5/2023 and 1,205 on 5/5/2024.